Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Višnja Matković"'
Autor:
Ana Fröbe, Blanka Jakšić, Višnja Matković, Herman Haller, Branka Petrić Miše, Dražan Butorac, Goran Vujić, Marina Kos, Tihana Boraska Jelavić, Snježana Tomić, Vanda Paradžik Pašalić, Ante Ćorušić, Ani Mihaljević Ferari, Ivana Canjko, Angela Prgomet Sečan, Danijela Vrdoljak Mozetić, Tanja Leniček, Gordana Lovrenčić-Prpić, Anastazija Aleksandrova Stanojević, Eduard Vrdoljak
Publikováno v:
Liječnički vjesnik, Vol 143, Iss 11-12, Pp 404-415 (2021)
Uterine cancer, according to the latest data from the 2017 Croatian Cancer Registry, is the fourth most common cancer in women in Croatia and ranking eighth in mortality. Most commonly, it is diagnosed in postmenopausal women at the age 50–79. Endo
Externí odkaz:
https://doaj.org/article/f76edb87605b4e399cbea9ffc01535c6
Autor:
Anastazija Aleksandrova Stanojević, Vanda Paradžik Pašalić, Kristina Katić, Herman Haller, Višnja Matković, Goran Vujić, Ani Mihaljević Ferari, Branka Petrić Miše, Tihana Boraska Jelavić, Ana Fröbe, Blanka Jakšić, Ingrid Belac Lovasić, Ante Ćorušić, Deni Karelović, Danijela Vrdoljak Mozetić, Ana Maria Alduk, Ivana Canjko, Snježana Tomić, Senija Eminović, Eduard Vrdoljak
Publikováno v:
Liječnički vjesnik, Vol 143, Iss 11-12, Pp 395-403 (2021)
Cervical cancer, in comparison with other gynecological malignancies, mainly affects younger women. It can be prevented through educational programs, vaccination, screening and early detection. In early stages it can also be effectively treated. Trea
Externí odkaz:
https://doaj.org/article/f1403865587445f69b080f10209e4090
Autor:
Branka Petrić Miše, Višnja Matković, Ingrid Belac Lovasić, Ana Fröbe, Tihana Boraska Jelavić, Kristina Katić, Ivana Canjko, Snježana Tomić, Ante Ćorušić, Damir Babić, Herman Haller, Deni Karelović, Mari Perić, Dinka Šundov, Goran Vujić, Blanka Jakšić, Eduard Vrdoljak
Publikováno v:
Liječnički vjesnik, Vol 143, Iss 11-12, Pp 416-428 (2021)
Ovarian and fallopian tube cancer, i.e., adnexal tumours, and primary peritoneal cancer is the sixth most common female cancer and the deadliest gynecologic tumor in Croatia. Hystologically, these tumors are most commonly of epithelial origin, a sero
Externí odkaz:
https://doaj.org/article/e25d5c9a7f2848b383b82adff66b3704
Publikováno v:
Libri Oncologici, Vol 49, Iss 1, Pp 10-18 (2021)
Introduction: Bevacizumab is a recombinant humanized anti-VEGF monoclonal antibody. It is an effective treatment for epithelial ovarian cancer, both in primary and recurrent disease. The incidence of ovarian cancer increases with advancing age. Despi
Externí odkaz:
https://doaj.org/article/c79f9be44b0d464cb009b07bbcdcaaf9
Publikováno v:
Libri Oncologici, Vol 49, Iss 1, Pp 48-50 (2021)
Choriocarcinoma is one of the histological types of entities called gestational trophoblastic neoplasia (GTN) that refers to a rare group of malignancies that are formed by abnormal proliferation of trophoblastic tissue. Choriocarcinoma is the most a
Externí odkaz:
https://doaj.org/article/0541d8d6025641e392781af3196d762e
Autor:
Dora Čerina, Višnja Matković, Kristina Katić, Ingrid Belac Lovasić, Robert Šeparović, Ivana Canjko, Žarko Bajić, Eduard Vrdoljak
Publikováno v:
Journal of Personalized Medicine, Vol 12, Iss 7, p 1176 (2022)
Today, in the era of precision medicine, the determination of genomic instability or other potentially targetable mutations, along with BRCA 1 and BRCA 2, is a crucial component of the diagnosis and treatment management of advanced ovarian cancer. Ad
Externí odkaz:
https://doaj.org/article/22e54795d5284118a83a11089ac95a9e
Publikováno v:
Libri Oncologici, Vol 49, Iss 1, Pp 48-50 (2021)
Choriocarcinoma is one of the histological types of entities called gestational trophoblastic neoplasia (GTN) that refers to a rare group of malignancies that are formed by abnormal proliferation of trophoblastic tissue. Choriocarcinoma is the most a
Autor:
Žarko Bajić, Blanka Jakšić, Ivana Canjko, Kristina Katić, Robert Šeparović, Eduard Vrdoljak, Dora Čerina, Višnja Matković, Ingrid Belac Lovasić, Marijo Boban, Branka Petrić-Miše
Publikováno v:
Journal of Oncology, Vol 2021 (2021)
Journal of Oncology
Journal of Oncology
Background. Although today it is almost preventable, cervical cancer still represents a significant cancer burden, especially in some developing parts of the world. Since the introduction of bevacizumab in the first-line treatment of metastatic disea
Autor:
Ivana Canjko, Kristina Katić, Dora Čerina, Eduard Vrdoljak, Žarko Bajić, Robert Šeparović, Ingrid Belac Lovasić, Višnja Matković, Stjepko Pleština, Blanka Jakšić, Ana Fröbe
Publikováno v:
Pathology and Oncology Research
Comprehensive genomic profiling (CGP) is gradually becoming an inevitable part of the everyday oncology clinical practice. The interpretation and optimal implementation of the results is one of the hot topics of modern-day oncology. According to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78aeadd0ab792e561b62c7460590b433
https://doi.org/10.3389/pore.2021.1609963
https://doi.org/10.3389/pore.2021.1609963
Publikováno v:
Ovarian cancer.
Introduction Bevacizumab is a recombinant humanized monoclonal antibody to vascular endothelial growth factor. It is an effective treatment for epithelial ovarian cancer, both in primary and recurrent disease. The incidence of ovarian cancer increase